Promore Pharma AB’s SEK 48.6 Million Rights Issue

Setterwalls advised Promore Pharma AB on the deal.Promore Pharma AB completed its rights issue of approximately SEK 48.6 million. Promore Pharma is a biopharmaceutical company specialized…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now